戻る Agenda
Pharmacovigilance Regulations: Updates
Session Chair(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
Pharmacovigilance Regulations: Updates
Speaker(s)
Impact of COVID-10 on PV compliance management
Vicki Edwards, RPH
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Current thinking on RSI
Elena Prokofyeva, MD, PHD, MPH
Federal Agency for Medicines and Health Products (FAMHP), Belgium
Head of Drug Safety Unit, Department of Research & Development, DG PRE
Update on industry requirement to use EVDAS for signal detection
Justin Daniels, PHD
Novartis Pharma GmbH, Germany
EU & UK QPPV
Medical Device Regulation
James Whitehead, MBA, MSC
Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Former Senior Director Device & Digital Safety - AstraZeneca